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 Abstract 
Human embryonic stem cells (ESC) are undifferentiated and are endowed with the 
capacities of self renewal and pluripotential differentiation. Adult stem cells renew their 
own tissue, but whether they can trans-differentiate to other tissues is still controversial. To 
understand the genetic program that underlies the pluripotency of stem cells, we compared 
the transcription profile of ESC with that of progenitor/stem cells of human hematopoietic 
and keratinocytic origins, along with their mature cells to be viewed as snapshots along 
tissue differentiation. ESC gene profile show higher complexity with significantly more 
highly expressed genes than adult cells. We hypothesize that ESC use a strategy of 
expressing genes that represent various differentiation pathways and selection of only a few 
for continuous expression upon differentiation to a particular target. Such a strategy may 
be necessary for the pluripotency of ESC. The progenitors of either hematopoietic or 
keratinocytic cells also follow the same design principle. Using advanced clustering, we 
show that many of the ESC expressed genes are turned off in the progenitors/stem cells 
followed by a further downregulation in adult tissues. Concomitantly, genes specific to the 
target tissue are upregulated towards matured cells of skin or blood. 
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 Introduction 
 
Human embryonic stem cells (ESC) exhibit self-renewal and pluripotential differentiation (1). 
Adult tissue specific stem cells renew their own tissue and may also exhibit plasticity by trans-
differentiation into cells of other tissues. Research on stem cells attracted recently the attention of 
the public as well as the scientific and medical community because of their potential for cell 
replacement therapy with the option to personalized stem cells produced by nuclear transfer (2). 
The gene expression profile of ESC can be highly informative with regard to their self renewal 
and pluripotency properties. Although some genes that are important for maintaining the 
undifferentiated state of ESC were identified (e.g. NANOG (3) OCT4 (4)) the genetic program 
and design principle that underlies the pluripotency of stem cells is not well understood. 
Recent work used microarray analysis to characterize the gene expression profile of several 
human ESC cell lines and to compare it to that of closely related tumors like embryonal 
carcinoma and seminoma or to a variety of somatic cell lines (5).  The results demonstrated the 
high similarity in expression profiles between the various ESC lines, the close relationship of 
ESC profiles to those of embryonal carcinoma or seminoma and a distant relationship to somatic 
cell lines. They identified 895 genes that were expressed in human ESC at higher level than in 
control samples. Another study compared ESC profiles to a mixture of RNA obtained from 
various adult tissues (universal RNA) assuming that it represents a reference point for 
differentiated adult cells (6).  In this study a group of 92 genes were found to be enriched in 
expression in all six human ESC tested and were considered a molecular signature of the 
stemness properties of ESC.   
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We wished to compare the expression profile of human ESC to that of defined adult tissues and 
their progenitors, which are related to the much sought for minor population of adult tissue stem 
cells. For this study we chose blood and epidermis because they exhibit tissue renewal throughout 
life, and the differentiated cells of such tissues have a short life span and do not divide. We 
isolated hematopoietic cells’ progenitors from whole peripheral or cord blood by adsorption to 
anti CD133 (7), and the keratinocytes’ progenitors by taking advantage of the differential 
expression in the hemidesmosomal integrins β1 and β4 of epidermal keratinocytes (8, 9). The 
expression profiles of ESC and of such cell populations represent snapshots of cell states, from 
embryonal stem cells through tissue progenitor to differentiated cells; comparison of such a 
sequence of expression profile may help to elucidate the gene expression pattern which is unique 
for embryonic stem cell and may be responsible for their properties. 
We found that ESC express significantly more genes than adult tissue cells; many of these genes 
are downregulated upon differentiation to adult tissue cells. The down-regulated genes that are 
unique in their expression to ESC include genes that were identified previously as responsible for 
pluripotency and self-renewal, such as NANOG (10)  OCT4 (4)  and others. Surprisingly many of 
the down-regulated genes are known to be expressed in a variety of other adult tissues. On the 
other hand, some other genes that are specific to the target tissue (e.g. epidermis, blood) are up-
regulated with respect to their expression in ESC. We suggest the hypothesis that in order to 
maintain their pluripotency, many differentiation options are primed in ESC by promiscuous gene 
expression just in case some of them will be needed for the target tissue towards which the ESC 
is instructed to differentiate.  
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 This represents a design principle of stem cells that accounts for both self renewal and 
pluripotency. A prime candidate for pluripotential differentiation is the parsimonious “just in 
time” strategy; expressing genes only when needed, i.e. at the moment of commitment to a 
particular differentiation path. The opposite extreme is the seemingly more wasteful “just in 
case” strategy, which keeps a wide repertoire of expressed genes, to be present in case a 
particular path is selected. Our results indicate that stem cells keep thousands of non specific 
genes expressed (“just in case”) that are selected for upregulation or quenched (if not needed) 
upon differentiation.  
Methods 
Isolation and characterization of cell samples used for microarrays analysis 
Human ESC were obtained from H9.2 cloned line, a derivative of H9 that was previously isolated 
from the blastocytes’ inner cell mass (11, 12).  Several surface markers typical of primate ESC 
(11, 12) were examined using immunofluorescent staining. The H9.2 cells were found to be 
positive for the surface markers SSEA4, TRA-1-60 and TRA-1-81. RT-PCR analyses further 
showed the expression of the pluripotency markers NANOG and OCT4. 
Similar to other ESC, once removed from its feeder layer and cultured in suspension (13), the 
H9.2 line formed Embryoid Bodies (EB), including cystic EB. Histology sections revealed 
different cell types within these EB. The injection of undifferentiated H9.2 cells into the hindlimb 
of SCID-beige mouse resulted in the generation of a teratoma which possessed representatives of 
the three germ layers. 
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 Human keratinocytes were obtained from 12 pooled neonatal foreskins as previously described 
(14) or from primary culture of normal human keratinocytes.  To obtain progenitor/stem cells 
from keratinocytes, we took advantage of their differential expression of  the integrins β1 and β4 
(8, 9).  The keratinocytes were separated into 3 fractions by differential adsorption on native 
collagen IV, a fundamental epidermal basement membrane component and a ligand of integrins 
β1 and β4. Rapidly adherent cells on collagen-IV coated plates were obtained after 0.5h of 
incubation and harvested as keratinocytes stem/progenitor cells (KSPC). Unadsorbed cells were 
re-plated on new collagen-IV coated plates and the cells adsorbed after 24h were harvested and 
collected as transit amplifying cells (TAC) whereas the unadsorbed cells after 24h were collected 
as differentiated keratinocytes (KDC). Cells from the three fractions were analyzed for 
clonogenicity and expression of known markers (14).  Fig. 1 demonstrates that KSPC show the 
highest clonogenicity potential and the expression of markers known to be characteristic to 
epidermal stem cells, like P63 and β–catenin as well as the absence of keratinocytes’ 
differentiation markers.   
Human progenitors for hematopoietic cells were obtained from pools of cord blood 
collected after placental separation and from peripheral blood collected by pheresis from adult 
normal donors primed with G-SCF for stem cells mobilization. Enriched hematopoietic 
stem/progenitor cells were isolated from those preparations, using the anti CD133 magnetic beads 
separation system (Miltenyi).  The non-selected cells were termed hematopoietic differentiated 
cells (HDC).  The yield of selected CD133 positive cells was 0.14% for cord blood and 0.7% for 
peripheral blood and the isolated cell populations were 80-85% positive for CD133 as assayed by 
FACS. Evidently the CD133+ cells contain CD34+ cells and a significant amount (~25%) of 
CD34+, CD38+ cells. Although hematopoietic stem cells are characterized by CD38- markers it 
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 is known that even such a population (CD34+, CD38-) is heterogeneous. The human CD133+ 
cells are considered a population of hematopoietic stem/ progenitor cells (15) and we defined 
them as HSPC.  To support this contention we compared the results of enriched expressed genes 
of HSPC in our samples with that of human cord blood samples characterized by LIN- CD34+ 
CD38-  reported by Ivanova et al (16). Out of 2500 Probe Sets (PS) with the highest fold change 
reported by them (16)1198 PS ((48%), 1055 genes) are common with our list derived from the 
CD133+ cells. The common genes include CD34, AC133, BMI1, TIE, HOXA10, FZD6, SOX4, 
TCF3, RUNX1, FLT3, LMO2, SCA1, MEIS1, MPL, TEK, SCA1, MDR1 and others. Theses genes 
are known to be important for the maintenance of hematopoietic stem cells. Hence, our CD133 
isolated hematopoietic cells (HSPC) represent a similar population to that of human LIN- CD34+ 
CD38- hematopoietic stem cells reported by Ivanova et al (16) .    
 
RNA extractions and microarray. Gene expression was measured by hybridization to 
Affymetrix U133A GeneChip® DNA microarrays, containing ~22,000 probe sets (PS). RNA 
extractions were performed by the RNA isolation reagent TRIzol®, and RNA integrity was 
assessed by gel electrophoresis. 10 µg total RNA was used to prepare biotinylated target cRNA 
according to Affymetrix™ procedures. 
Bioinformatics. For probe-level data analysis, we tried several methods of probe set 
summarization: MBEI (http://www.biostat.harvard.edu/complab/dchip/), RMA 
(http://www.bioconductor.org) and MAS 5.0. The reported results did not depend on the 
particular method used and MAS 5.0 expression values and detection calls were kept. Expression 
levels < 30 were thresholded to 30 and log2 was taken to generate the final gene expression 
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 matrix. For clustering analysis, a new very efficient version (O. Barad, M.Sc. thesis, Weizmann 
Inst. of Science, unpublished) of the Super Paramagnetic Clustering method (17) was used to 
cluster the data. Prior to clustering, the expression levels for each PS were centered and 
normalized.  
Tissue Classification of Expressed genes. The MAS 5.0 signal intensities of the GNF dataset 
(http://expression.gnf.org/cgi-bin/index.cgi)  of Su et al. (18), that contain expression data for 21 
tissues were converted into quantile scale (19) as follows: the expression levels for each gene in 
all  tissues were divided into 10 equal bins for signal levels above 50. Signal below or equal to 50 
was termed zero quantile. The expression level of each gene in all tissues analyzed is represented 
by the quantile numbers between 0 and 10.  The maximum difference between two neighbouring 
values in the sorted quantile vector is defined as the “gap” index. The “gap” criterion was used to 
convert the expression profiles into a binary form. For each probe set, we first checked whether 
there is a gap with value of 3 or higher. Tissues in which expression was detected above the 
threshold gap were interpreted as over-expressing the gene and marked as 1. The rest of the 
tissues were referred to as under-expressing the gene and marked as 0. In this manner each 
expression profile of a PS over the tissues was classified to a particular binary pattern.  The probe 
sets were divided into 3 groups: (i) probe sets with quantile numbers = 0 for all tissues represent 
genes absent in all tissues (ii). Probe sets with only one or two tissues above the gap represent 
tissue-specific or “tissue-affiliated” genes, and (iii) probe sets with over-expression in more than 
3 tissues are called genes "expressed in multiple tissues”. For example, if a gene is expressed in 
the various tissues with all the levels, ranging between 1 and 10, the gap is 1 and the gene is 
labelled as "expressed in multiple tissues". If the gene is expressed at a level of 10 in one tissue 
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 and a level of 2 in all other tissues, the gap is 8 and the gene is tissue specific for the tissue with 
the expression level of 10. 
 
Results 
 
ES Cells Express More Genes than Differentiated Cells. To assess the changes of gene 
expression during differentiation, we studied 17 samples: 3 ESC, 4 HSPC and 4 HDC, 3 KSPC 
and 3 KDC. We wished to know whether ESC and tissue adult cells express a similar or different 
number of genes.  The gene expression results of the ESC and adult differentiated cells (10 
samples) were analyzed as follows: out of 22,215 probe sets (PS) on the chip, 15,918 PS with at 
least one “present” call, obtained from MAS 5.0, were kept. The log2-transformed expression 
levels for each PS were centered and normalized. The values of each gene were between -1 and 
+1, where 0 is the average expression of this gene in these samples. A value of 0.3 in a particular 
sample means a significant expression above the average in this sample. This criterion was used 
by others (20) and we also defined a PS with a centered and normalized value above 0.3 as highly 
expressed. Table 1 shows that 4550 PS satisfy this criterion in ESC; this number is significantly 
higher than the number of similarly identified genes that are highly expressed genes in the adult 
differentiated state (~3000 PS).  
We wanted to classify these genes in order to know whether they are specific to the embryonic 
state and for this we studied the expression levels of these 4550 PS in a wide group of adult 
tissues. This was done using the GNF dataset (http://expression.gnf.org/cgi-bin/index.cgi) 
described by Su et al (18) who studied the expression level of 21 human tissues (see Methods). 
The 4550 PS were converted from U133A PS to U95A PS and then were classified into 3 groups 
as follows: (a) Genes that are highly expressed in ESC but not in any adult tissue that was 
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 analyzed (18) (low expression is considered less than a signal of 50 as calculated by the 
affymetrix MAS 5.0 software) (b) tissue-specific genes, expressed in 1-2 tissues (c) genes 
expressed in multiple adult tissues (> 2 tissues). This analysis was performed by enumeration of 
graded expression levels for each PS in every tissue (see Methods). 
We found that from 4550 PS that are expressed in ESC, 700 PS  are not expressed in any of the 
adult tissues studied by Su et al (18). This number is similar to that obtained by others (5). Most 
(3300) of the remaining PS are expressed in multiple adult tissues and approximately 1000 PS are 
tissue specific genes (fig 2). Examples for tissue-specific genes expressed in a variety of tissues 
can be seen in table 2. 
 
Marked Down-Regulation of Expressed Genes Upon Stem Cell Differentiation. The above 
results suggest that upon differentiation from ESC to adult cells there is a marked down 
regulation of expressed genes. To test this we analyzed two groups of samples which may 
represent virtual steps in the differentiation pathways from ESC to adult cells: 
 
(A) Hematopoietic (H) pathway; ESC →  HSPC →  HDC (3+4+4 samples), and 
(B) Keratinocytic (K) pathway; ESC →  KSPC →  KDC (3+3+3 samples). 
It is clear that the three cell stages depicted in the above pathways do not represent real 
differentiation but comparison of snapshots of cell stages derived from different sources. 
Nevertheless they can be considered as representatives of different stages between embryonic 
stem cells and mature tissue cells. For each group the genes were filtered using ANOVA (21) and 
false discovery rate (FDR) (22) was controlled at 0.05. This left 8290 PS (6293 genes) that vary 
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 significantly over the three kinds of cell states in group (A) and 5432 (4301 genes) for group (B); 
There are two sources to this difference. The first is the different numbers of samples in the two 
groups. Discarding two samples from group (A) and repeating the ANOVA with 3+3+3 samples 
yields about 7000 PS (instead of 8290) that pass with FDR of 0.05. The further reduction to 5432 
PS is due to the fact that the within-group variance of the genes in the K pathway significantly 
exceeded that of the same groups in the H pathway. We present in Figs. 3A and 3B the 
expression levels of the significantly varying PS. The black line shows the expression level of 
8290 PS in ESC from highly expressed PS (left side) to the lower expressed PS (right side). The 
green dots show the expression of the same genes in HSPC (Fig. 3A) and KSPC (Fig. 3B) and the 
red dots represent the expression of the same genes in adult cells (HDC Fig 3A, KDC Fig 3B). 
The data showed that ESC (black line, Fig. 3) express many genes at a higher level than the other 
cells analyzed and the majority of transcripts exhibited marked downregulation along the 
differentiation pathway: 4392 PS (3483 genes) were downregulated as cells differentiate from 
ESC to HDC, this was accompanied by up-regulation of a smaller group of 2638 PS (1988 
genes), with low expression in ESC and high in the HDC. A similar pattern was seen in the 
keratinocytic pathway (Fig. 3B). 
Clustering analysis shows distinct stem cells specific genes. We clustered (17) the samples of 
groups A (8290 PS) and B (5432 PS) separately, to identify distinct differentiation-related 
variations of the expression profiles, and to assign genes to clusters of similar patterns of 
expression. Fig. 4 depicts the expression matrix after clustering of the genes in the H (Fig. 4A) 
and K (Fig. 4B) pathways. Six clusters are clearly shown:  clusters H1, H2 and H3 contain ESC 
genes that were down-regulated along differentiation in the H pathway and K1, K2, K3 were 
downregulated in the K pathway. Clusters 4 and 5 contain genes that were upregulated along the 
virtual differentiation pathways (H or K). Clusters 6 contain genes expressed only in adult 
 11
 stem/progenitor cells, whereas clusters 3 contain genes that show expression only in ESC. 
Clearly, ESC and adult stem progenitor cells have different gene expression profiles. The lists of 
genes in each of the clusters are given in tables S2-S13 in supplementary data 
(http://www.weizmann.ac.il/physics/complex/compphys/downloads/michalm/). 
Table 3 presents selected genes that were previously shown to be typical of one of the cell stages, 
and belong to one of the six clusters in Fig. 4. Clusters 1 and 2 contain genes that are common to 
ESC and adult stem/progenitors cells and therefore may represent the “stemness” genes as 
previously defined (16, 23). It should be noted, however, that many genes, well known to be 
markers for undifferentiated ESC or related to ESC self-renewal [e.g. NANOG, POU5F1 (OCT4), 
SOX2, FOXH1, TDGF1 (Cripto), LeftyA & B, Thy1 (3, 4, 24-26) – Table 3] belong to clusters H3 
and K3 (Fig. 4), and thus are suppressed in HSPC or KSPC and seem to be unique to the ESC. 
Their roles are apparently taken over in the tissue stem/progenitor cells by those of clusters H6 or 
K6, which show expression only in the stem/progenitor cells, and indeed contain genes known to 
be essential for the self-renewal and tissue differentiation and development [e.g. TP73L (p63), 
ITGB4 and BNC for skin (27-29), and e.g. BMI1, CD34, TIE, KIT, TAL1 (SCL), and RUNX1 for 
blood (30-32) – Table 3]. It is of interest that the genes present in cluster 6 (H6, K6, Fig. 4) show 
exclusive expression in progenitor cells of either blood or epidermis. For example CD34 and KIT, 
known markers of hematopoietic stem cells are included in this cluster. The recently identified 
BMI1 that function to maintain hematopoietic stem cells pluripotency and RUNX1 a transcription 
factor that regulates haematopoiesis and involved in leukaemia are also included in H6. In the 
KSPC (epidermis keratinocyte pathway) a notable example is p63 that was shown by Knock-out 
to be essential for skin development (33, 34). Hemidesmosomal and adherence junction 
components such as integrin β4 and BPAG1 and BPAG2 keep keratinocyte attached to the 
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 epidermal basement membrane, thereby participating in the maintenance of the undifferentiated 
state of keratinocyte stem cells. The fact that P63, integrin β4, BPAG1 and BPAG2 also belong to  
cluster K6 indicates that this cluster contains genes related to progenitor keratinocyte cells. 
Basonuclin a zinc finger protein associated with increasing transcription of rRNA and epithelial 
proliferation (35) is also included in K6. We can conclude that the cell population isolated by us 
as representative of stem/progenitor cells indeed exhibit many characteristic genes for the young 
immature epidermis progenitors and they are not expressed in the adult stage of this tissue. On 
the other hand the clusters H4, H5 and K4, K5 contain genes that are markedly upregulated along 
the differentiation pathways towards the target tissue (blood or epidermis). These groups of genes 
include blood cells specific genes like IGG, MHC, Haptoglobin and Fc to mention only a few. In 
the keratinocytes pathway completely different set of genes is upregulated in K4 and K5 and 
include epidermal differentiation markers like Loricrin, Filaggrin and keratins 10 and others 
(Table 3).  
Search for a core of ESC expressed genes, some of which may represent an ESC 
signature. The unique gene list of clusters 3 (H3 and K3, Fig. 4 and table 3) may contain 
signature genes for ESC since they are expressed only in ESC when clustering is performed on 
either of the pathways. To search for a common core of ESC genes we intersected the H3 and K3 
gene lists. This resulted in a list of 179 genes that contain genes highly enriched in ESC relative 
to differentiated and stem/progenitors of both blood and epidermis, but not necessarily relative to 
other tissues. These genes may be regarded as candidates for serving as embryonic stem cell 
signature. However, checking the behaviour of these genes in the data of Su et al (18), we 
discovered that 98 genes (out of the 179) are expressed in one or more adult differentiated tissue. 
We also checked this list of genes against available data on expression of their orthologs in 
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 murine adult tissue stem cells. Of the remaining 81 genes 15 are expressed either in other adult 
stem cells (36, 37) or in other adult tissue as found by checking them individually in the 
Genecards dataset (http://bioinfo.weizmann.ac.il/cards/index.shtml), leaving 66 candidate genes 
(table S1 in supplementary data 
http://www.weizmann.ac.il/physics/complex/compphys/downloads/michalm/). This list may 
shrink further if more adult stem cell lineages are studied. This list includes most of the well 
known genes that were analyzed in various ESC systems and shown to be essential for 
pluripotency and self-renewal, like OCT4, LIN28, TDGF1, LeftB, SOX2, and others. Twenty 
significant genes from this list are presented in table 4. Among these genes is OCT4, a 
transcription factor that is expressed in ESC and down regulated upon differentiation (38). 
Similarly, NANOG is another transcription factor that is involved in pluripotency and suppression 
of differentiation and NANOG deficient ESC show limited pluripotency and produce only 
endoderm like cells (3 , 10). TDGF1 or cripto is an autocrine growth factor and stimulates cell 
proliferation at the expense of differentiation. TDGF1, when deficient, is embryonic lethal at post 
gastrulaion due to failure of morphogenesis (39). LEFTB is a TGFβ related protein that regulates 
left-right early embryonic patterning (40). The transcription factor SOX2 that regulates FGF4 
expression, was found in all human ESC and is also a marker of neural progenitors. Frizzled 
(FZD), is a receptor for WNT and part of the WNT/β-catenin pathway. β-catenin activates the 
TCF transcription factor leading to proliferation and inhibition of differentiation (41, 42). 
Constitutive expression of SOX2 maintains the progenitor state and inhibits neuronal 
differentiation (43). It may operate together with OCT4 to specify the three body layers at 
implantation (24). The list includes also CDC6 that is required for initiation of DNA-replication 
(44). Noteworthy in this list are genes that encode for protein involved in remodelling of 
chromatin. For example, SMARCA1 an homolog of the yeast general transcription activator of the 
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 SWI/SNF family members which known to be involved in chromatin remodelling (45). This 
complex includes also members of SWI2/SNF2 family and histone deacetylase (HDAC). This 
suggests that a significant part of the regulation of gene expression in ESC is by epigenetic 
changes that regulate chromatin alteration.   
Discussion 
In this study we analyzed the expression profile of human ESC line 9.2 and compared it to 
the expression profiles of adult tissues - differentiated cells (blood and keratinocytes) as well as 
their progenitor cells. This comparison, based on clustering analysis, allowed the construction of 
virtual differentiation pathways from ESC to the differentiated cell of the particular tissue and to 
identify the genes whose expression may constitute a profile signature for the various steps in this 
pathway. The results indicate that cluster 3 (table 3) contains genes well-known for their role in 
the properties of ESC that are absent in adult stem cells. Cluster 6 (table 3) includes genes that 
are essential for the function of blood and skin stem cells but absent from ESC. This may cast 
doubt on the notion that all stem cells share a common genetic signature (16, 23). 
An important question concerning the gene expression profile of ESC is to try to define the 
gene list which is ESC-specific or highly enriched and may mark the signature of ESC. These 
genes should be characterized by their contribution to self-renewal, pluripotency and control of 
differentiation. A recent study (6) described a list of 92 genes that are common to six hESC lines 
and not expressed (at least 3 fold lower) in a mixture of RNA (universal RNA) which represents 
many adult differentiated tissues. Five out the 92 genes were absent from our Affymetrix chip. Of 
the remaining 87, we found 66 (76%) in clusters H1, H2 and H3 (Fig. 4), i.e. in clusters of genes 
with high expression in ESC and down-regulation in HDC. Only 26 of these 66 genes belong to 
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 cluster H3 and 40 to cluster H1+H2. This does not contradict (6); note that their 92 genes were 
selected by comparing expression in human ESC with a universal RNA that was derived from 
adult differentiated tissues, but not from adult tissue stem cells. Their list of 92 includes relatively 
many genes that are expressed in tissue stem cells (that belong to clusters 1 or 2). Only 9 of the 
26 genes (marked by X in table 4) genes appear also in our list of 66 candidate ESC signature 
genes. In another study, significantly enriched genes in human ESC were identified, including 
specific genes coding for receptors (5) . We found that all of the most significant 25 receptor 
genes reported in that work and 15 out of the 25 most significant enriched genes (5) were present 
in clusters 1, 2 and 3 (Fig 4). Among the most significant receptors we found the WNT receptor 
Frizzled 7 (FZD7) and BMP receptor that has been recently shown to induce human ESC to 
differentiate into trophoblast (46).  
An interesting result of our data was the decrease of complexity of gene expression upon 
differentiation from ESC to adult cells (table 1). The clustering results also showed that overall in 
the hematopoietic pathway 4392 PS (3483 genes) were downregulated and 2638 PS (1998 genes) 
were upregulated, while in the keratinocyte pathway 3417 PS (2758 genes) were downregulated 
and 1423 PS (1115 genes) were upregulated. The massive downregulation is consistent with the 
“just in case” design principle underlying pluripotential differentiation. We suggest the 
hypothesis that in order to maintain their potential for pluripotency, ESC “keep their options 
open” by promiscuous gene expression, maintaining thousands of genes at intermediate levels, 
and selecting only a few for continuous expression that are needed for differentiation to the target 
tissue. The rest will be down-regulated upon commitment to a cell fate for which they are not 
needed. This is a selection model of gene expression during differentiation and the down-
regulation of genes that are not needed is required for establishing the differentiated state. It is 
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 very likely that this strategy is made possible by maintaining an open chromatin structure at the 
stem cell stage and epigenetic modification upon differentiation (47, 48). A similar model was 
previously proposed in the case of hematopoietic stem cell differentiation on the basis of 
expression of erythroid or granulocyte markers in the progenitor cell prior to commitment (49) 
and recent work extended this also to the analysis of genes expression by microarrays in the 
hematopoietic system (20, 50). Our study demonstrates the generality of this model and extends it 
to human ESC and adult stem cells at the level of global gene expression.  
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 Figure legends  
 
Figure 1 Clonogenicity assay and expression of epidermal specific markers of keratinocyte 
fractions. (A) Clonogenicity assay: after selection of isolated keratinocytes from human 
epidermis on type IV collagen (see Methods), 2000 cells of each fraction were plated per well (in 
triplicate), and after two weeks in culture, keratinocyte colonies were scored. Numbers represent 
averaged cFu / abortive colonies (8, 14). (B) Western blot analysis of specific markers (27) in 
keratinocyte fractions isolated as in A. KSPC, Keratinocyte Stem/Progenitor Cells; TAC, Transit 
Amplifying Cells; and KDC, Keratinocytes Differentiated Cells. 
 
Figure 2. Classification of tissues expression for the ESC expressed genes.  
The list of 4550 PS (table 1) that are highly expressed in ESC were classified according to their 
expression in 21 tissues based on the GNF dataset (see methods) into 3 groups : (A) ESC specific 
genes that are not expressed in any adult tissue (expression signal less than 50 in all tissues.) (B) 
Tissue-specific genes expressed in 1-2 tissues C, Genes expressed in multiple adult tissues (> 2 
tissues). 
 
Figure 3. Expression levels of probe-sets (PS) that vary significantly between ESC, adult 
stem cells and differentiated cells. The PS were ordered according to their ESC expression 
levels, marked by black circles that form a line. The expression levels in HSPC or KSPC are 
indicated by green dots and in HDC and KDC by red dots. (A) Expression levels of 8290 PS that 
vary between ESC, HSPC and HDC. (B) Expression of 5432 PS that vary between ESC, KSPC 
and KDC. Only PS with P-values that passed ANOVA at an FDR level of 0.05 were plotted (21). 
In (A) 4392 PS (3483 genes) are down-regulated and 2638 PS (1988 genes) are up-regulated with 
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 differentiation. In (B) 3417 PS (2758 genes) and 1423 PS (1115 genes) are up- and down- 
regulated, respectively.   
 
Figure 4. Clustering analysis of PS expression levels in hematopoietic and keratinocytic 
pathways. The expression levels of the PS taken from Fig. 3 were centered and normalized and 
the PS were reordered according to the dendrogram produced by the SPC algorithm (17). (A) 
Expression matrix of 8290 PS in ESC, HSPC, and HDC. (B) Expression matrix of 5432 PS in 
ESC, KSPC and KDC. (C) Overlaps between the related 6 clusters were calculated relatively to 
keratinocyte clusters. 
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Table 1. Distribution of Gene Expression in Embryonic Stem Cell and Adult Celli 
 ESC KDC HDC 
Probe sets on the chip 22,215 22,215 22,215 
Probe sets with at least one "Present" call 15,918 15,918 15,918 
Probe sets with normalized value more than 0.3 4550 2982 3217 
 
 
                                                 
i The numbers in the third row were obtained as follows: each probe set was centered and 
normalized over the 10 samples (ESC -3, KDC-3, HDC-4) used for the analysis. Probe sets with a 
value above 0.3 in the samples of each group (ESC, KDC and HDC) were selected and presented. 
 
 
Table 2. Selected Tissue Specific Genes Expressed in Human Embryonic Stem Cells as 
obtained from Fig 2 by checking the GNF dataset. 
Symbol Title Tissue ESC Signal 
CD24 CD24 antigen Blood 4818.20 
GRN Granulin Blood 728.43 
MMD monocyte to macrophage differentiation-associated Blood 956.80 
COL1A1 collagen, type I, alpha 1 Bone 2167.10 
CHN1 chimerin (chimaerin) 1 Brain 357.90 
CNTNAP2 contactin associated protein-like 2 Brain 315.60 
DBN1 drebrin 1 Brain 744.40 
DCTN1 dynactin 1 Brain 311.60 
KRT10 keratin 10  Skin 883.10 
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OPHN1 oligophrenin 1 Brain 457.53 
RTN3 reticulon 3 Brain 670.03 
TMSNB thymosin, beta, identified in neuroblastoma cells Brain 1550.60 
YWHAQ tyrosine 3-monooxygenase/tryptophan Brain 3343.10 
ZIC1 Zic family member 1 (odd-paired homolog, Drosophila) Brain 1011.53 
DDR1 discoidin domain receptor family, member 1 Brain + Lung 694.03 
RTN4 reticulon 4 Brain + Testis 1859.57 
COL11A1 collagen, type XI, alpha 1 Cartilage 158.97 
PIM1 pim-1 oncogene Hematopoietic  255.17 
CRYZ crystallin, zeta (quinone reductase) Lens 186.73 
APOA2 apolipoprotein A-II Liver 387.20 
APOC1 apolipoprotein C-I Liver 387.47 
NGFRAP1 nerve growth factor receptor  Ovary + Testis  5376.73 
FHL2 four and a half LIM domains 2 Skeletal Muscle 221.47 
FLOT2 flotillin 2 Skin 632.37 
CALD1 caldesmon 1 Smooth Muscles 629.40 
MYL9 myosin, light polypeptide 9, regulatory Smooth Muscles 669.37 
 
 
Table 3. Selected genes identified in clusters of Fig. 4 that are known to be important in the various cell stages 
  
Hematopoietic 
clusters       
Keratinocytic 
clusters     
Clust. Identifier Symbol Short Name Clust. Identifier Symbol Short Name 
                
H1 X52078.1 TCF3 transcription factor 3 K1 BG393795 TCF3 transcription factor 3 
  NM_014366.1 NS nucleostemin   AK026674.1 TCF4 transcription factor 4 
  BF510715 FGF4 FGF4   BF510715 FGF4 FGF4 
  L37882.1 FZD2 frizzled 2   U91903.1 FRZB frizzled-relat. prot. 
  NM_000435.1 NOTCH3 Notch 3   NM_001845.1 COL4A1 collagen, type IV, α1 
  AF029778 JAG2 jagged 2   AK026737.1 FN1 fibronectin 1 
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  AL556409 GAL galanin   NM_021953.1 FOXM1 forkhead box M1 
  NM_005842.1 SPRY2 sprouty 2   AL556409 GAL galanin 
  NM_001903.1 CTNNA1 α catenin 1   NM_005359.1 MADH4 SMAD4 
                
H2 AK026674.1 TCF4 transcription factor 4 K2 BC004912.1 BPAG1 bullous pemph. ag.1 
  NM_001331.1 CTNND1 δ catenin 1   NM_003798.1 CTNNAL1 α catenin like 1 
  M87771.1 FGFR2 KGF receptor   NM_022969.1 FGFR2 KGF receptor 
  NM_006017.1 CD133 prominin-like 1   NM_003012.2 SFRP1 frizzled-relat. prot. 1 
  NM_003506.1 FZD6 frizzled homolog 6   NM_000165.2 GJA1 connexin 43 
  NM_000165.2 GJA1 connexin 43      
  NM_005631.1 SMO smoothened         
  NM_003107.1 SOX4 SRY-box 4      
  BF508662 SPRY1 sprouty 1         
  U54826.1 MADH1 SMAD1         
  AK027071.1 TSC22 TGFβ-stimulated prot.         
                
H3 AF268613.1 POU5F1 OCT4 K3 AF268613.1 POU5F1 OCT4 
  NM_024674.1 LIN-28 RNA-binding protein   NM_024674.1 LIN-28 RNA-binding protein 
  NM_003212.1 TDGF1 Cripto   NM_003212.1 TDGF1 Cripto 
  NM_024865.1 NANOG ES transcription factor   NM_024865.1 NANOG ES transcription factor 
  NM_003240.1 EBAF left-right determ. fact. A   NM_003240.1 EBAF left-right determ. fact. A 
  NM_020997.1 LEFTB left-right determ. fact. B   NM_020997.1 LEFTB left-right determ. fact. B 
  NM_003577.1 UTF1 ES transcription factor 1   NM_003577.1 UTF1 ES transcription factor 1 
  AA218868 THY1 Thy-1 cell surface ag.   AA218868 THY1 Thy-1 cell surface ag. 
  NM_001290.1 LDB2 LIM domain binding 2   NM_001290.1 LDB2 LIM domain binding 2 
  AB028869.1 BIRC5 survivin   NM_001168.1 BIRC5 survivin 
  NM_003923.1 FOXH1 forkhead box H1   NM_003923.1 FOXH1 forkhead box H1 
  NM_002006.1 FGF2 FGF2   NM_002006.1 FGF2 FGF2 
  AF202063.1 FGFR4 FGFR4   NM_002011.2 FGFR4 FGFR4 
  L07335.1 SOX2 SRY-box 2   L07335.1 SOX2 SRY-box 2 
  M13077.1 ALPP alkaline phosphatase   M13077.1 ALPP alkaline phosphatase 
  NM_016941.1 DLL3 delta-like 3   NM_016941.1 DLL3 delta-like 3 
  NM_005585.1 MADH6 SMAD6   NM_005585.1 MADH6 SMAD6 
  NM_001134.1 AFP alpha-fetoprotein   NM_001134.1 AFP alpha-fetoprotein 
  NM_007295.1 BRCA1 breast cancer 1   AF005068.1 BRCA1 breast cancer 1 
  X95152 BRCA2 breast cancer 2   X95152 BRCA2 breast cancer 2 
  U96136.1 CTNND2 δ catenin 2   AF035302.1 CTNND2 δ catenin 2 
  NM_017412.1 FZD3 frizzled homolog 3   NM_017412.1 FZD3 frizzled homolog 3 
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  NM_020634.1 GDF3 growth diff. factor 3   NM_020634.1 GDF3 growth diff. factor 3 
  U91903.1 FRZB frizzled-related protein   NM_001463.1 FRZB frizzled-related protein 
 NM_012259.1 HEY2 hairy/enh. of split 2 YPRW  AF098951.2 ABCG2 ATP-bind. cassette G2 
 U43148.1 PTCH patched     
 U77914.1 JAG1 jagged 1     
 NM_004821.1 HAND1 heart and neural crest 1     
 NM_003392.1 WNT5A development regulator     
                
H4 NM_014676.1 PUM1 pumilio 1 K4 NM_005620.1 S100A11 calgizzarin 
  D87078.2 PUM2 pumilio 2   NM_002965.2 S100A9 calgranulin B 
  BC005912.1 FCER1A Fc frag. of IgE, high aff. I   NM_002966.1 S100A10 calpactin I 
  NM_019102.1 HOXA5 homeo box A5   NM_005978.2 S100A2 CAN19 
  BC005332.1 IGKC Ig const. κ    NM_003125.1 SPRR1B cornifin 
  BG340548 IGHM Ig heavy const. m   NM_002203.2 ITGA2 integrin α2 
  NM_005574.2 LMO2 LIM domain only 2   NM_005547.1 IVL involucrin 
  AA573862 HLA-A MHC I, A   NM_005046.1 KLK7 kallikrein 7 
  X76775 HLA-DMA MHC II, DM α   M19156.1 KRT10 keratin 10 
          X57348 SFN stratifin 
          BC000125.1 TGFB1 TGFβ1 
                
H5 NM_001738.1 CA1 carbonic anhydrase I K5 AL356504 FLG filaggrin 
  NM_000129.2 F13A1 coag. factor XIII, A1   AF243527 KLK5 kallikrein 5 
  U62027.1 C3AR1 compl. comp. C3a R1   NM_006121.1 KRT1 keratin 1 
  AF130113.1 CYB5-M cytochrome b5 prec.   NM_002274.1 KRT13 keratin 13 
  NM_001978.1 EPB49 eryth. memb. prot. 4.9   NM_000427.1 LRN loricrin 
  NM_002000.1 FCAR Fc frag. of IgA   NM_002963.2 S100A7 psoriasin 1 
  NM_004106.1 FCER1G Fc frag. of IgE, high aff. I   NM_003238.1 TGFB2 TGFβ2 
  NM_004107.1 FCGRT Fc frag. of IgG, α   NM_004245.1 TGM5 transglutaminase 5 
  NM_005143.1 HP haptoglobin         
  NM_000558.2 HBA1 hemoglobin α1         
  H53689 IGL@ Ig l locus         
  BE138825 HLA-F MHC I, F         
  NM_002120.1 HLA-DOB MHC II, DO β         
                
H6 M81104.1 CD34 CD34 antigen K6 NM_001717.1 BNC basonuclin 
  NM_005180.1 BMI1 B lymph. MLV ins. reg.   AF091627.1 TP73L p63 
  NM_000222.1 KIT SCF receptor   NM_002204.1 ITGA3 integrin α3 
  NM_005424.1 TIE endothelial RTK   NM_000213.1 ITGB4 integrin β4 
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  NM_003189.1 TAL1 SCL   NM_001723.1 BPAG1 bullous pemph. ag.1 
  D43968.1 RUNX1 RUNT TF 1   NM_000494.1 BPAG2 collagen XVII α1 
  AL134303 EGFL3 EGF-like-domain 3   NM_000227.1 LAMA3 laminin α3 
  NM_018951.1 HOXA10 homeo box A10         
 
 
Table 4.  Select 20 Significant Genes in Human Embryonic Stem Cellsi. 
Gene Symbol 
Present 
in (6) Title ESC Signal Fold change* 
ZIC1  Zic finger transcription factor 1011.53 257.85 
TDGF1 X teratocarcinoma-derived growth factor 1 1494.87 194.45 
CRABP1 X retinoic acid binding protein  4379.50 138.00 
LIN-28 X RNA-binding protein LIN-28 1759.90 102.78 
NANOG X hypothetical protein FLJ12581 394.10 85.91 
FLJ10884  hypothetical protein FLJ10884 1707.63 64.11 
NLGN  neuroligin 222.60 51.72 
TMSNB  thymosin, beta 1550.60 46.26 
POU5F1 X OCT4 1641.17 35.51 
CYP26A1 X cytochrome P450, family member 632.47 27.69 
FGF13  fibroblast growth factor 13 504.33 23.66 
SOX2 X SRY (sex determining region Y)-box 2 340.17 23.31 
LEFTB X left-right determination 749.30 20.77 
FOXH1  forkhead box H1 248.93 19.15 
FZD7  frizzled homolog 7 996.23 16.65 
CDC6  cell division cycle 6 295.43 12.24 
REPRIMO  mediator of the p53-dependent G2 arrest 240.87 10.74
PRODH  proline dehydrogenase (oxidase) 1 353.63 9.24
SPS X selenophosphate synthetase 902.83 6.51
SMARCA1  SWI/SNF related 448.03 6.27 
 
 
 
